We are live on ! Find out more

449 hedge funds and large institutions have $10.3B invested in Sanofi in 2016 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 161 increasing their positions, 142 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more funds holding in top 10

Funds holding in top 10: 79 (+2)

27% more call options, than puts

Call options by funds: $34.9M | Put options by funds: $27.4M

13% more repeat investments, than reductions

Existing positions increased: 161 | Existing positions reduced: 142

10% more capital invested

Capital invested by funds: $9.38B → $10.3B (+$962M)

10% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 40

1.28% more ownership

Funds ownership: 17.86%19.14% (+1.3%)

0% more funds holding

Funds holding: 448449 (+1)

Holders
449
Holders Change
+1
Holders Change %
+0.22%
% of All Funds
11.98%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.24%
New
44
Increased
161
Reduced
142
Closed
40
Calls
$34.9M
Puts
$27.4M
Net Calls
+$7.5M
Net Calls Change
+$5.06M

SNY Hedge Fund Activity: Q2 2016 in Review

449 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2016, worth a combined $10.3B — up 10% from $9.38B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new SNY positions and 40 closed out — a net gain of 4 holders — while 161 added to existing stakes and 142 trimmed.

The largest buyer was Boston Partners, adding an estimated $301M. The largest seller was Fidelity Investments, cutting an estimated $108M.

  • 449 institutional investors held Sanofi (SNY) as of Q2 2016, up from 448 in Q1 2016.
  • Funds reported $10.3B of Sanofi stock for Q2 2016, up 10% quarter-over-quarter.
  • 44 funds opened new Sanofi positions in Q2 2016 and 40 closed out, a net change of +4 holders.
  • The largest Sanofi buyer in Q2 2016 was Boston Partners, an estimated $301M added.
  • The largest Sanofi seller in Q2 2016 was Fidelity Investments, an estimated $108M sold.

Based on aggregated 13F filings for Q2 2016.